Henlius 2021 Annual Results: New Record in Performance, Evol

SHANGHAI, March 16, 2022 /PRNewswire/ -- Henlius (2696.HK) announced its annual results for the year ended December 31st, 2021, sharing the company's recent noteworthy progress and achievements.

Related Keywords

China , Australia , Philippines , United States , Shanghai , Turkey , Chinese , Kostenloser Wertpapierhandel , Wenjie Zhang , Prnewswire Henlius , Fosun Pharma , European Union , Reporting Period , Latest Practicable Date , Drug Applications , Executive Director , Henlius , 021 , Nnual , Results , Record , Performance , Evolving , Iopharma ,